Global Eptifibatide Market is forecasted to grow with a CAGR of 2.8%

Share

Global Eptifibatide Market is forecasted to grow with a CAGR of 2.8%

Published: May-2019
Category : Pharmaceutical
Author: SPER Market Research Staff

Eptifibatide is a cyclic heptapeptide extracted from a protein found in the venom of the southeastern dwarf poisonous snake (Sistrurus miliarius barbouri) that binds to platelet receptor glycoprotein and hinders platelet collection. It has a place with the class of the arginin-glycin-aspartat-mimetics and reversibly ties to platelets. Eptifibatide has a short half-life. The drug is the third inhibitor of GPIIb/IIIa that has found broad acceptance after the specific antibody abciximab and the non-peptide tirofiban entered the global market.

SPER

Market Research

SPER Market Research is a global business consulting and market research firm.

Secure Payments

SPER Payment Options

Connect with us